Children's Hospital of Orange County
Brief Summary The purpose of this observational study is to better understand how vitamin D levels affect the gut microbiome (the bacteria that live in the intestines) in children who are newly diagnosed with acute lymphoblastic leukemia (ALL). Researchers want to learn whether low vitamin D levels are linked to changes in gut bacteria and whether this may affect how children with ALL respond to chemotherapy. The main questions this study aims to answer are: * Are the gut bacteria different in children with ALL who have low vitamin D levels compared to those with normal vitamin D levels at the time of diagnosis? * How do vitamin D levels relate to changes in gut bacteria and related body processes before and after induction chemotherapy? Researchers will compare children who have low vitamin D levels with those who have normal vitamin D levels to see if there are differences in their gut bacteria and how those bacteria change during early treatment. The stool samples will be studied in specialized laboratories to better understand how vitamin D and gut bacteria interact. The results of this study may help doctors understand whether monitoring and managing vitamin D levels could improve care and treatment outcomes for children with ALL. Participants will: Have four study visits: * Screening: Review and sign consent/assent forms, review of Inclusion/Exclusion Criteria, medical history, and current medications * At diagnosis (baseline): Review of medications, laboratory results, Vitamin D level, Fecal Sample Collection * Day 29-32 - At the end of induction chemotherapy: Review of medications, laboratory results, Vitamin D level, Fecal Sample Collection and Adverse event assessment * Day 90-97 after Induction: Review of medications, laboratory results, Vitamin D level, Fecal Sample Collection and Adverse event assessment
Detailed description: This pilot observational study will evaluate how vitamin D (VitD) levels are related to the gut microbiome in children newly diagnosed with acute lymphoblastic leukemia (ALL), and how these relationships change during early chemotherapy treatment. Aim 1: To determine whether vitamin D status affects the gut microbiome at the time of ALL diagnosis. The study hypothesizes that children with vitamin D deficiency will have lower gut microbiome diversity and different microbial and metabolomic profiles compared to children with sufficient vitamin D levels. A baseline stool…
Inclusion Criteria: * Ages 0-18 years * Newly diagnosed with acute lymphoblastic leukemia, including B-cell ALL, T-cell ALL, mixed phenotype actue leukemia (MPAL), and Philadelphia-positive or Philadelphia-like ALL. Exclusion Criteria: * Diagnosed with other malignancies, congenital gastrointestinal or bowel diseases, or inflammatory bowel diseases. * Hypersensitivity to vitamin D. * Pregnant.